These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16885716

  • 1. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL.
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [Abstract] [Full Text] [Related]

  • 2. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
    Armstrong VW, Schuetz E, Zhang Q, Groothuisen S, Scholz C, Shipkova M, Aboleneen H, Oellerich M.
    Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
    [Abstract] [Full Text] [Related]

  • 3. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry.
    Brown NW, Gonde CE, Adams JE, Tredger JM.
    Clin Chem; 2005 Mar; 51(3):586-92. PubMed ID: 15650031
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R, Chusney G, Loucaidou M, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [Abstract] [Full Text] [Related]

  • 5. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 6. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 7. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RL, Lynch SV, Shaw LM, Pond SM.
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [Abstract] [Full Text] [Related]

  • 8. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.
    Salm P, Rutherford DM, Taylor PJ, Black MJ, Pillans PI.
    Clin Biochem; 2000 Oct; 33(7):557-62. PubMed ID: 11124341
    [Abstract] [Full Text] [Related]

  • 10. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A, Hermida J, Tutor JC.
    Ups J Med Sci; 2008 Oct; 113(1):103-10. PubMed ID: 18521804
    [Abstract] [Full Text] [Related]

  • 11. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients.
    Staatz CE, Taylor PJ, Tett SE.
    Ther Drug Monit; 2002 Oct; 24(5):607-15. PubMed ID: 12352932
    [Abstract] [Full Text] [Related]

  • 12. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
    Tomita T, Homma M, Yuzawa K, Ohkohchi N, Hori T, Kaneko M, Hasegawa Y, Kojima H, Nagasawa T, Kohda Y.
    Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
    [Abstract] [Full Text] [Related]

  • 13. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K.
    Transplant Proc; 2014 Apr; 46(3):758-60. PubMed ID: 24767342
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S, Nagano H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Monden M, Doki Y, Mori M.
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Jun; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
    Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Johnson AG.
    Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
    [Abstract] [Full Text] [Related]

  • 17. Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood.
    Armendáriz Y, García S, Lopez RM, Pou L.
    Ther Drug Monit; 2005 Dec; 27(6):766-9. PubMed ID: 16306852
    [Abstract] [Full Text] [Related]

  • 18. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N.
    Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J, Fernández MC, Tutor JC.
    Clin Lab; 2005 Feb; 51(1-2):43-5. PubMed ID: 15719703
    [Abstract] [Full Text] [Related]

  • 20. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.
    Zhang Q, Simpson J, Aboleneen HI.
    Ther Drug Monit; 1997 Aug; 19(4):470-6. PubMed ID: 9263391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.